Ginkgo Says Milbank Probe Rebuts Short-Seller's Fraud Claim
Life sciences company Ginkgo Bioworks acknowledged Monday that it "received an informal inquiry" from the U.S. Department of Justice following a short-seller's allegations of financial misconduct, but said an internal probe...To view the full article, register now.
Already a subscriber? Click here to view full article